A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

P.J.D. van Steenwijk; T.H. Ramwadhdoebe; M.J.G. Lowik; C.E. van der Minne; D. Berends-van der Meer; L.M. Fathers; A.R.P.M. Valentijn; J. Oostendorp; G.J. Fleuren; B.W.J. Hellebrekers; M.J.P. Welters; M.I. van Poelgeest; C.J.M. Melief; G.G. Kenter; S.H. van der Burg

doi:10.1007/s00262-012-1292-7

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

P.J.D. van Steenwijk, T.H. Ramwadhdoebe, M.J.G. Lowik, C.E. van der Minne, D. Berends-van der Meer, L.M. Fathers, A.R.P.M. Valentijn, J. Oostendorp, G.J. Fleuren, B.W.J. Hellebrekers, M.J.P. Welters, M.I. van Poelgeest, C.J.M. Melief, G.G. Kenter, S.H. van der Burg

Obstetrics and gynaecology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1485-1492
Journal	Cancer Immunology and Immunotherapy
Volume	61
Issue number	9
DOIs	https://doi.org/10.1007/s00262-012-1292-7
Publication status	Published - 2012

Access to Document

10.1007/s00262-012-1292-7

Cite this

van Steenwijk, P. J. D., Ramwadhdoebe, T. H., Lowik, M. J. G., van der Minne, C. E., Berends-van der Meer, D., Fathers, L. M., Valentijn, A. R. P. M., Oostendorp, J., Fleuren, G. J., Hellebrekers, B. W. J., Welters, M. J. P., van Poelgeest, M. I., Melief, C. J. M., Kenter, G. G., & van der Burg, S. H. (2012). A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. Cancer Immunology and Immunotherapy, 61(9), 1485-1492. https://doi.org/10.1007/s00262-012-1292-7

@article{2a3e1074a83a4a5baa73e9f7d8115d70,

title = "A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions",

author = "{van Steenwijk}, P.J.D. and T.H. Ramwadhdoebe and M.J.G. Lowik and {van der Minne}, C.E. and {Berends-van der Meer}, D. and L.M. Fathers and A.R.P.M. Valentijn and J. Oostendorp and G.J. Fleuren and B.W.J. Hellebrekers and M.J.P. Welters and {van Poelgeest}, M.I. and C.J.M. Melief and G.G. Kenter and {van der Burg}, S.H.",

year = "2012",

doi = "10.1007/s00262-012-1292-7",

language = "Undefined/Unknown",

volume = "61",

pages = "1485--1492",

journal = "Cancer Immunology and Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "9",

}

van Steenwijk, PJD, Ramwadhdoebe, TH, Lowik, MJG, van der Minne, CE, Berends-van der Meer, D, Fathers, LM, Valentijn, ARPM, Oostendorp, J, Fleuren, GJ, Hellebrekers, BWJ, Welters, MJP, van Poelgeest, MI, Melief, CJM, Kenter, GG & van der Burg, SH 2012, 'A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions', Cancer Immunology and Immunotherapy, vol. 61, no. 9, pp. 1485-1492. https://doi.org/10.1007/s00262-012-1292-7

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. / van Steenwijk, P.J.D.; Ramwadhdoebe, T.H.; Lowik, M.J.G. et al.

In: Cancer Immunology and Immunotherapy, Vol. 61, No. 9, 2012, p. 1485-1492.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

AU - van Steenwijk, P.J.D.

AU - Ramwadhdoebe, T.H.

AU - Lowik, M.J.G.

AU - van der Minne, C.E.

AU - Berends-van der Meer, D.

AU - Fathers, L.M.

AU - Valentijn, A.R.P.M.

AU - Oostendorp, J.

AU - Fleuren, G.J.

AU - Hellebrekers, B.W.J.

AU - Welters, M.J.P.

AU - van Poelgeest, M.I.

AU - Melief, C.J.M.

AU - Kenter, G.G.

AU - van der Burg, S.H.

PY - 2012

Y1 - 2012

U2 - 10.1007/s00262-012-1292-7

DO - 10.1007/s00262-012-1292-7

M3 - Article

C2 - 22684521

VL - 61

SP - 1485

EP - 1492

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 9

ER -